Aetna Medicare (Medicare Advantage) · all interventional pain
✓ conditional · medicare advantage
Criteria checklist
0 of 1 ticked- enumerated: no
- description: Aetna Medicare Advantage applies the Traditional Medicare coverage FLOOR. For procedures with an NCD/LCD (SCS, DRG, PNS, ITDD, MILD/PILD, facet, ESI, kyphoplasty, SI fusion), use the SAME criteria as the corresponding `policies/<procedure>/medicare-in-ky-*.md` cell — the plan cannot be more restrictive — plus Aetna MA's prior-authorization process. For R&N procedures where Medicare is silent (Intracept, ReActiv8, endoscopic nerve transection), the plan MAY apply its own publicly- posted internal criteria (e.g., Aetna's commercial CPB stance) — pull the plan's policy for those.
POINTER cell. Criteria = the Traditional Medicare cell per procedure (NCD/LCD floor) + Aetna MA's PA process. The 2024 CMS rule bars MA plans from applying internal criteria more restrictive than a governing NCD/LCD; internal criteria are permitted only for R&N procedures (Intracept, ReActiv8, endoscopic). For those R&N procedures, Aetna MA likely applies Aetna's commercial CPB positions — confirm via billing. Plan PA process/vendor not independently verified (needs_reverification).
Ticks are a documentation aid — nothing is stored; they reset on reload.
Prior-auth pathway
- required: yes
- pathway: Aetna Medicare Advantage prior authorization (confirm process/vendor)
Provenance
- authority:
- type: medicare_advantage
- floor: Traditional Medicare NCD/LCD per procedure — see policies/<procedure>/medicare-in-ky-*.md
- plan um: Aetna Medicare prior authorization / utilization management (vendor/process to confirm)
- applies because: Per CMS-4201-F (2024) / 42 CFR 422.101, an MA plan must follow Traditional Medicare coverage criteria where an NCD/LCD fully establishes them, and cannot be more restrictive; plan internal criteria are allowed only where Medicare is silent (R&N procedures)
- source: https://www.ecfr.gov/current/title-42/section-422.101
- effective: 2024-01-01 · payor last reviewed: — · we verified: 2026-07-24 · v1
Change history
- 2026-07-24framework cells (MA x3, Medicaid IN/KY, VA): re-reviewed regulatory basis 2026-07-24 (42 CFR 422.101/CMS-4201-F, 405 IAC Art.5, KY KAR 907:3:130, 38 CFR 17.38(b) all current); plan/state-specific operational details (MA PA vendor, Medicaid interactive fee-schedule PA flags + MCO scopes, VA gated SEOC catalog/Optum manual/image-only CPG) remain gated -> needs_reverification kept; last_verified 2026-07-24
86bd4bd0b9 - 2026-06-29Add Medicare Advantage pointer cells (Aetna, Humana Gold HMO, HumanaChoice PPO)
86a5e15292